January 10, 2018

By Glenn Ellis Depending on whom you talk to, medical marijuana (also known as cannabis) is either a panacea for everything from cancer, to chronic pain, to epilepsy or it’s a dangerous and illegal drug with no place in medicine. In 1996, California voters passed Proposition 215, making the Golden State the first in the […]

by

VANCOUVER, British Columbia, Jan. 10, 2018 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that its research arm, Cannevert Therapeutics Ltd. (“CTL”) has signed a clinical research agreement with the FDI Clinical Research (FDI-CR) in San Juan, Puerto Rico, to conduct the first human study of […]

by

By Beryl Lieff BenderlyJan. 10, 2018 , 2:20 PM Biochemist Jahan Marcu has found “a very rewarding career” working to assure the safety of medicines. “It is really touching to see patients using our products and leaving opioids behind,” says Adam Kavalier, a phytochemist who works in the same industry. The fast-growing field where these […]

by

Newswise — NEW YORK (January 10, 2018) – The Department of Defense (DOD) has awarded $1.3 million to fund a clinical trial at Montefiore Health System that will examine the effect of a cannabis compound called Cannabidivarin (CBDV) on irritability and repetitive behaviors in children with autism spectrum disorder (ASD). These characteristics are common in […]

by

SEATTLE, WA, Jan. 09, 2018 (GLOBE NEWSWIRE) — CFN Media Group (“CannabisFN”), the leading creative agency and media network dedicated to legal cannabis, announces publication of an exclusive CEO interview and article discussing Ehave Inc.(OTCQB: EHVVF) and its proprietary patient management platform, currently in use in both the medical marijuana and mental health industries. In the interview, CEO […]

by

<!– SHOW ARTICLE –> INDIANAPOLIS (AP) — An influential Republican lawmaker in the Indiana House of Representatives said Friday that the Legislature should study the possibility of legalizing medical marijuana. Rep. Matt Lehman, the majority floor leader, says he is sponsoring a resolution calling for an interim study committee to research medical pot after the […]

by

What happened Progress in crafting marijuana plants that are high in the non-psychoactive marijuana cannabinoid cannabidiol (CBD) and tobacco that’s low in nicotine sent 22nd Century Group, Inc. (NYSEMKT:XXII) rocketing 157% higher in 2017, according to SP Global Market Intelligence. So what 22nd Century is a plant biotechnology company that genetically engineers and breeds tobacco and cannabis […]

by